Gene-modified autologous hematopoietic stem cell therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Gene-modified autologous hematopoietic stem cell therapy, covering 2024-06-14 to 2024-06-14. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent β-thalassemia [NA]